Fabtech Technologies Limited is coming up with its Initial Public Offering (IPO) to raise capital for working capital requirements, acquisitions, and general corporate purposes. The IPO comprises entirely a fresh issue of 1.21 crore equity shares. The total offer size aggregates up to Rs. 230.35 crore.
The IPO opens on September 29, 2025, and closes on October 1, 2025. The shares will be listed on NSE and BSE on Tuesday, October 7, 2025. Here’s everything you need to know.
GMP of Fabtech Technologies IPO
As of September 29, 2025, the shares of Fabtech Technologies Limited in the grey market were trading at a 10.47 percent premium. The shares in the Grey Market traded at Rs. 211. This gives it a premium of Rs. 20 per share over the cap price of Rs. 191.
Overview of Fabtech Technologies Limited
Fabtech Technologies Limited was incorporated in 2018 and is a biopharma engineering company specializing in turnkey projects and customized engineering solutions. The company designs and delivers cleanroom facilities, modular systems, and process equipment that meet international regulatory standards.
The company provides end-to-end services, including design, engineering, manufacturing, installation, and project management for global clients. Fabtech offers clean water solutions with equipment for purified water, pure steam generation, and water for injection systems, with capacities from 500 LPH to 50,000 LPH.
The company also provides clean air solutions supporting industries such as life sciences, food and beverage, IT, semiconductors, and aeronautics. With expertise across the biopharma manufacturing life cycle, Fabtech helps clients take products from concept to market. As of July 31, 2025, the company employed 185 permanent staff members.
Promoters of Fabtech Technologies Limited
Fabtech Technologies Limited’s promoters are Aasif Ahsan Khan, Hemant Mohan Anavkar, Aarif Ahsan Khan, and Manisha Hemant Anavkar. They bring decades of experience in engineering, pharmaceuticals, and international project execution. This IPO is a completely fresh issue without an offer for sale. No promoter or shareholder is selling equity in this offering.
Also Read: Stocks to Buy: Sun Pharma, HAL and 6 other stocks to buy now for an upside of up to 43%
Lead Managers of Fabtech Technologies Limited IPO
Unistone Capital Private Limited is the Book Running Lead Manager of the IPO. Bigshare Services Private Limited acts as the registrar for the issue.
Objectives of the IPO Offer
Fabtech Technologies Limited’s IPO proposes to utilize the net proceeds for three main objectives. The company will allocate Rs. 127 crore towards funding working capital requirements to support ongoing operations and expansion.
Additionally, Rs. 30 crore will be directed towards pursuing inorganic growth initiatives through acquisitions. The remaining funds will be used for general corporate purposes to strengthen operations and support long-term business growth.
Financial Analysis of Fabtech Technologies Limited
Fabtech Technologies Limited’s consolidated net revenue from operations has increased from Rs. 226.14 crore in FY24 to Rs. 326.67 crore in FY25, which represents a growth of 44.45 percent. The net profit has increased by 70.65 percent, from Rs. 27.22 crore in FY24 to Rs. 46.45 crore in FY25. Fabtech Technologies Limited’s revenue and net profit have grown at a CAGR of 29.83 percent and 46.2 percent, respectively, over the last two years.
In terms of return ratios, the company’s ROCE and ROE stand at 30.46 percent and 24.46 percent, respectively. Jaro Institute of Technology Management & Research Limited has an earnings per share (EPS) of Rs. 14.34, and its debt-to-equity ratio is 0.32x.
Fabtech Technologies Limited Vs Peers
The company has no directly listed comparable peers in India. Its business model focuses on providing turnkey engineering and cleanroom solutions, primarily catering to pharmaceutical, biopharma, and healthcare industries across global markets.
Strengths of Fabtech Technologies Limited
- Strong international presence across 62 countries enhances global market reach and client base.
- Proven expertise in turnkey engineering and cleanroom solutions ensures consistent project execution.
- Robust financial performance with strong profitability ratios builds investor confidence.
- Experienced promoters provide strategic direction and industry leadership.
- Diverse product portfolio reduces dependence on any single segment or geography.
Weaknesses of Fabtech Technologies Limited
- Dependence on the pharmaceutical and healthcare industries increases sector concentration risk.
- High working capital requirements strain cash flows during expansion phases.
- Intense competition from global engineering and cleanroom companies pressures pricing.
- Exposure to international markets subjects the company to foreign exchange fluctuations.
- Business depends on regulatory approvals and compliance in multiple jurisdictions.
Conclusion
Fabtech Technologies Limited IPO offers investors exposure to the growing pharmaceutical engineering and cleanroom solutions market. Strong financials, global presence, and sectoral demand support the company’s growth outlook. Investors should carefully evaluate strengths, weaknesses, and industry risks before making subscription decisions.
Written By – Nikhil Naik
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
